A detailed history of Sphera Funds Management Ltd. transactions in Rezolute, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,196,938 shares of RZLT stock, worth $5.88 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
1,196,938
Previous 1,707,999 29.92%
Holding current value
$5.88 Million
Previous $7.34 Million 20.96%
% of portfolio
1.06%
Previous 1.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.13 - $5.31 $2.11 Million - $2.71 Million
-511,061 Reduced 29.92%
1,196,938 $5.81 Million
Q2 2024

Aug 14, 2024

BUY
$2.29 - $5.79 $1.63 Million - $4.12 Million
711,289 Added 71.36%
1,707,999 $7.34 Million
Q3 2023

Nov 14, 2023

SELL
$1.32 - $2.1 $210,126 - $334,292
-159,187 Reduced 13.77%
996,710 $1.32 Million
Q2 2022

Aug 15, 2022

BUY
$2.6 - $3.85 $3.01 Million - $4.45 Million
1,155,897 New
1,155,897 $3.73 Million

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $191M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.